Rafael Holdings Inc (NYSE:RFL)
| 2.00 Delayed Data As of Sep 22 |  -0.075 / -3.62%Today’s Change | 1.55 Today|||52-Week Range 2.52 | +6.68% Year-to-Date |
| SECTOR Finance | INDUSTRY Real Estate Development | MARKET CAP $49.3M |
Company Description
Rafael Holdings, Inc. owns interest in commercial real estate assets and clinical stage pharmaceutical companies. It operates through the Real Estate and Pharmaceuticals segments. The Real Estate segment refers to the real estate holdings. The Pharmaceuticals segment is comprised of debt interests and warrants in Rafael Pharmaceuticals and a majority equity interest in LipoMedix Pharmaceuticals. The company was founded in 2017 and is headquartered in Newark, NJ.
Contact Information
Rafael Holdings, Inc. 520 Broad Street Newark New Jersey 07102 |
Employees
Shareholders
| Other institutional | 6.69% |
| Mutual fund holders | 5.05% |
| Individual stakeholders | 26.17% |
Top Executives
| William Conkling | President & Chief Executive Officer |
| David A. Polinsky | Chief Financial Officer |
| Gus Kodersha | Chief Technical Operations Officer |
| Barbara Ann Ryan | Investor Relations Contact |
| Joyce J. Mason | Secretary |
